112 related articles for article (PubMed ID: 38727326)
21. Effects of Cost Sharing on Ophthalmic Care Utilization in the Affordable Care Act Marketplace.
Hatcher JB; Lin G; Moran CP; Al Awamlh SAH; Sulieman L; Morales NG; Berkowitz ST; Patel S; Lindsey J
Ophthalmic Epidemiol; 2024 Apr; 31(2):159-168. PubMed ID: 37042706
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.
Leslie RS; Tirado B; Patel BV; Rein PJ
J Manag Care Spec Pharm; 2014 Dec; 20(12):1193-203. PubMed ID: 25443513
[TBL] [Abstract][Full Text] [Related]
23. Effect of Out-of-Pocket Cost on Medication Initiation, Adherence, and Persistence among Patients with Type 2 Diabetes: The Diabetes Study of Northern California (DISTANCE).
Karter AJ; Parker MM; Solomon MD; Lyles CR; Adams AS; Moffet HH; Reed ME
Health Serv Res; 2018 Apr; 53(2):1227-1247. PubMed ID: 28474736
[TBL] [Abstract][Full Text] [Related]
24. Comparison of statin adherence among beneficiaries in MA-PD plans versus PDPs.
Jung K; McBean AM; Kim JA
J Manag Care Pharm; 2012 Mar; 18(2):106-15. PubMed ID: 22380470
[TBL] [Abstract][Full Text] [Related]
25. Direct medical costs of ischemic heart disease in urban Southern China: a 5-year retrospective analysis of an all-payer health claims database in Guangzhou City.
Xie P; Li X; Guo F; Zhang D; Zhang H
Front Public Health; 2023; 11():1146914. PubMed ID: 37228711
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance.
DiStefano MJ; Kang SY; Parasrampuria S; Anderson GF
JAMA Health Forum; 2023 May; 4(5):e231090. PubMed ID: 37234016
[TBL] [Abstract][Full Text] [Related]
27. A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior.
Leslie RS; Gilmer T; Natarajan L; Hovell M
J Manag Care Spec Pharm; 2016 May; 22(5):526-38. PubMed ID: 27123914
[TBL] [Abstract][Full Text] [Related]
28. Government and private insurance medical programs as well as MDVIP, an update.
Edlich RF; Winters KL; Brit LD; Long WB
J Long Term Eff Med Implants; 2004; 14(3):243-50. PubMed ID: 15301667
[TBL] [Abstract][Full Text] [Related]
29. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
[TBL] [Abstract][Full Text] [Related]
30. Comparison of oral anticoagulation use and adherence among Medicare beneficiaries enrolled in stand-alone prescription drug plans vs Medicare Advantage prescription drug plans.
Newman TV; Gabriel N; Liang Q; Drake C; El Khoudary SR; Good CB; Gellad WF; Hernandez I
J Manag Care Spec Pharm; 2022 Feb; 28(2):266-274. PubMed ID: 35098746
[No Abstract] [Full Text] [Related]
31. Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular Disease.
Luo J; Feldman R; Callaway Kim K; Rothenberger S; Korytkowski M; Hernandez I; Gellad WF
JAMA Netw Open; 2023 Jun; 6(6):e2317886. PubMed ID: 37307000
[TBL] [Abstract][Full Text] [Related]
32. The PRICE clinic for low-income elderly: a managed care model for implementing pharmacist-directed services.
Stebbins MR; Kaufman DJ; Lipton HL
J Manag Care Pharm; 2005 May; 11(4):333-41. PubMed ID: 15871644
[TBL] [Abstract][Full Text] [Related]
33. Do Medicare Advantage Rebates Reduce Enrollees' Out-of-Pocket Spending?
Nicholas LH; Wu S
Med Care Res Rev; 2020 Oct; 77(5):474-482. PubMed ID: 30382801
[TBL] [Abstract][Full Text] [Related]
34. Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs.
Wong WB; Seetasith A; Hung A; Zullig LL
PLoS One; 2023; 18(1):e0280570. PubMed ID: 36656871
[TBL] [Abstract][Full Text] [Related]
35. Compliance with biologic therapies for rheumatoid arthritis: do patient out-of-pocket payments matter?
Curkendall S; Patel V; Gleeson M; Campbell RS; Zagari M; Dubois R
Arthritis Rheum; 2008 Oct; 59(10):1519-26. PubMed ID: 18821651
[TBL] [Abstract][Full Text] [Related]
36. Medication Nonadherence Among Medicare Beneficiaries with Comorbid Chronic Conditions: Influence of Pharmacy Dispensing Channel.
Iyengar RN; LeFrancois AL; Henderson RR; Rabbitt RM
J Manag Care Spec Pharm; 2016 May; 22(5):550-60. PubMed ID: 27123916
[TBL] [Abstract][Full Text] [Related]
37. Out-of-pocket costs and oral cancer medication discontinuation in the elderly.
Kaisaeng N; Harpe SE; Carroll NV
J Manag Care Spec Pharm; 2014 Jul; 20(7):669-75. PubMed ID: 24967520
[TBL] [Abstract][Full Text] [Related]
38. Medicare Coverage and Out-of-Pocket Costs of Quadruple Drug Therapy for Heart Failure.
Faridi KF; Dayoub EJ; Ross JS; Dhruva SS; Ahmad T; Desai NR
J Am Coll Cardiol; 2022 Jun; 79(25):2516-2525. PubMed ID: 35738713
[TBL] [Abstract][Full Text] [Related]
39. Medicare: looking for pareto optimal changes.
Christensen S
Inquiry; 1992; 29(4):426-39. PubMed ID: 1473866
[TBL] [Abstract][Full Text] [Related]
40. Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.
Hwang TJ; Jain N; Lauffenburger JC; Vokinger KN; Kesselheim AS
JAMA Intern Med; 2019 Mar; 179(3):374-380. PubMed ID: 30640379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]